Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 70377-126

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 70377-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Image01)

Label for Mycophenolic Acid Delayed-Release Tablets, USP 180 mg, a prescription oral tablet. The label includes storage instructions, pharmacist dispensing guidance, manufacturer details (Biocon Pharma Inc., Iselin, NJ), and tablet count (120 tablets). Packaging states each tablet contains mycophenolate sodium equivalent to 180 mg mycophenolic acid.*

FDA Label Image

Bottle Label (Image02)

Label for Mycophenolic Acid Delayed-Release Tablets, USP 360 mg by Biocon Pharma Inc. The label includes storage instructions, pharmacist dispensing advice, manufacturer's and labeler's information, barcode, and states the package contains 120 tablets.*

FDA Label Image

Image Description (Structure0001)

Chemical structure diagram of the active ingredient Mycophenolic Acid showing its molecular configuration with functional groups, including carboxylate, hydroxyl, methyl, and methoxy groups, as well as a sodium ion (Na+).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.